Literature DB >> 1457672

Septicemia in 980 patients at a university hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989.

H F Geerdes1, D Ziegler, H Lode, M Hund, A Loehr, W Fangmann, J Wagner.   

Abstract

A total of 980 episodes of clinically and bacteriologically proven septicemia were included in four prospective 1-year studies at a 1,300-bed university hospital in Berlin between 1979 and 1989. The incidence was 8.1 per 1,000 admissions. The percentage of patients with severe underlying diseases increased significantly from 67% to 95% over the decade. Septicemia due to gram-positive bacteria decreased from 47.3% in 1979 to 43.7% in 1986 and increased again to 51.2% in 1989. Septicemia due to gram-negative organisms decreased constantly from 45.0% in 1979 to 39.8% in 1989. The most frequently isolated species were Escherichia coli (26.4%), Staphylococcus aureus (18.9%), coagulase-negative staphylococci (10.2%), enterococci (7.7%), viridans streptococci (6.4%), Klebsiella species (5.5%), and pneumococci (5.0%). The overall mortality rate decreased significantly from 33.6% in 1979 to 20.8% in 1989. Mortality for episodes of septicemia due to gram-positive bacteria (25.5%) was higher than that for septicemia due to gram-negative bacteria (18.3%). Mortality rates associated with polymicrobic and fungal septicemia were higher than the overall mortality rate.

Entities:  

Mesh:

Year:  1992        PMID: 1457672     DOI: 10.1093/clind/15.6.991

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  23 in total

1.  Antibiotic susceptibility in aerobic gram-negative bacilli isolated in intensive care units in 39 French teaching hospitals (ICU study).

Authors:  V Jarlier; T Fosse; A Philippon
Journal:  Intensive Care Med       Date:  1996-10       Impact factor: 17.440

2.  Prognostic factors associated with improved outcome of Escherichia coli bacteremia in a Finnish university hospital.

Authors:  A Kuikka; A Sivonen; A Emelianova; V V Valtonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-02       Impact factor: 3.267

Review 3.  Enterobacter spp.: pathogens poised to flourish at the turn of the century.

Authors:  W E Sanders; C C Sanders
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

4.  Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study.

Authors:  L Leibovici; M Paul; O Poznanski; M Drucker; Z Samra; H Konigsberger; S D Pitlik
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

Review 5.  The Cost-Effectiveness of Rapid Diagnostic Testing for the Diagnosis of Bloodstream Infections with or without Antimicrobial Stewardship.

Authors:  Elina Eleftheria Pliakos; Nikolaos Andreatos; Fadi Shehadeh; Panayiotis D Ziakas; Eleftherios Mylonakis
Journal:  Clin Microbiol Rev       Date:  2018-05-30       Impact factor: 26.132

Review 6.  The problem of sepsis. An expert report of the European Society of Intensive Care Medicine.

Authors: 
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

7.  Identification of genes in an extraintestinal isolate of Escherichia coli with increased expression after exposure to human urine.

Authors:  T A Russo; U B Carlino; A Mong; S T Jodush
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

8.  Existing data sources for clinical epidemiology: The North Denmark Bacteremia Research Database.

Authors:  Henrik C Schønheyder; Mette Søgaard
Journal:  Clin Epidemiol       Date:  2010-08-09       Impact factor: 4.790

9.  Enterobacteriaceae bacteremias among cancer patients: an observational cohort study.

Authors:  Andrés F Henao-Martínez; Guido R González-Fontal; José R Castillo-Mancilla; Ivana V Yang
Journal:  Int J Infect Dis       Date:  2013-01-10       Impact factor: 3.623

Review 10.  Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.

Authors:  Edwin S Van Amersfoort; Theo J C Van Berkel; Johan Kuiper
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.